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Abstract 
Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone) is one of the non-
volatile and nontoxic compounds of ginger. It is also called vanillylacetone 
with a crystalline solid form which is sparingly soluble in water and more 
soluble in ether. The contribution of this compound in ginger is about 
9.25%. The chemical structure is made of a phenolic ring with methoxy 
group attached to benzene ring. Gingerol can be heated to form zingerone 
by retroaldol reaction. It has been reported that zingerone has multiple 
pharmacological activities. It is effective against diarrhoea causing entero-
toxigenic bacteria that leads to infant death. It is also used against intestinal 
gastric, oxidative stress, weak immunity, obesity. During its activity against 
cancer, it governs the expression of different cell cycle protein and TGF-β1 
expression. Antioxidant response is controlled by inducing the activity of 
ROS neutralising enzymes like superoxide dismutase, catalase and glutathi-
one reductase. It can also reduce various inflammations by restricting the 
activity of interleukins. This review summarizes the multiple pharmacology 
activities of zingerone against various important diseases like cancers, tu-
mors, inflammations, oxidative conditions, microbial infections, biofilm 
formations, thrombosis and other diseases. In addition, the molecular regu-
lation of these pharmacological responses by zingerone is also critically 
discussed.   
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Introduction 
Ginger (Zingiber officinale  Roscoe)  is well known for its medicinal proper-
ties and its use in spices. It contains various minerals and vitamins which 
are the basic need of human diet. Ginger is a traditional medicine, having 
immense active ingredients used for the treatment of numerous diseases (1, 
2). Ginger has antidiabetic, anti-inflammatory, anticancer, analgesic, hepa-
toprotective efficacy (3). According to the literature, more than 60 active 
volatile and non-volatile compounds have already been reported in leaves 
and rhizome of ginger. The major volatile components found in rhizome 
essential oil of ginger are zingiberene, curcumene and farnesene b-
sesquiphellandrene (4, 5). The non-volatile compounds present in the rhi-
zome of Z. officinale are gingerols, shogaols, paradols and zingerone (4-6). 
The contribution of zingerone in ginger is about 9.25% (2). Zingerone is also 
found in the floral parts of Bulbophyllum sp. like Bulbophyllum patens and B. 
baileyi (7, 8). In B. patens, zingerone was found to be highest that is 930 ppm 
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in the labellum while other parts like sepals, petals and 
column were having 167 ppm, 95 ppm, 51 ppm respective-
ly (7).  
 However, zingerone is an important medicinal ac-
tive compound and is predominantly found in ginger. It 
bears a strong, spicy, pungent odour reminiscent of ginger 
(9). It also known as vanillylacetone and its IUPAC name is 
4-(4-hydroxy-3-methoxyphenyl)-2-butanone (C11H14O3) (10) 
(Fig. 1). It is a non-volatile constituent which is naturally 
produced directly during drying of ginger and also indi-
rectly by thermal degradation of gingerols or shogaols (2). 
Gingerol is heated to produce zingerone and aldehyde in 
retro aldol reaction (Fig. 2). In addition, zingerone is an 
important compound present in ginger oleoresin and it is 
very difficult to extract. However, few extraction methods 
are developed to extract this compound from ginger oleo-
resin. In a study, it was identified as major compound in 
ethanol extraction of ginger oleoresin by using ultrasound 
at a frequency of 42 kHz and at a temperature of 60 °C (11). 
In another study, the supercritical CO2 extraction method 
was optimized to 25 MPa pressure, 45 °C temperature and 
150 min time for extraction of zingerone in ginger oleores-
in (12). This compound can also be synthesized artificially 
(13, 14). Initially, under basic conditions both vanillin 
and acetone are allowed for aldol condensation to form 
dehydrozingerone. Then the dehydrozingerone is hydro-
genated to form zingerone (14). In addition, five quinoline 






phenylquinolin-3-yl) methyl)-2-methoxyphenol were syn-
thesized (15). 
 In 2017, the total global burden of health was more 
than 2.4 billion (16). This includes more than 362 million of 
cardiovascular diseased patients, 230 million of cancer 
diseases, 133 million of diabetes and endocrine diseases, 
84 million of digestive diseases and 40 million of liver dis-
eases (16). However, these non-communicable diseases 
contribute more than 1.4 billion to the global health bur-
den (16). Although several synthetic drugs are available 
against these diseases, herbal medicines are very effective 
without any side effect. Zingerone is a non-volatile constit-
uent of ginger and is found to be a promising herbal medi-
cine against multiple health disorders (17) (Fig. 3, Table 1). 
Zingerone treatment can reduce cancer, tumor, inflamma-
tion, cardiac diseases, thrombosis, obesity, diabetes and 
many other diseases (17-22). It also plays important role 
against platelet aggregation in blood (22). In cancer, use of 
this active compound can inhibit the expression of trans-
forming growth factor-beta 1 (TGF-β1) to control the can-
cer metastasis. It also regulates the Bax, Bcl2 and cyclin     
d proteins to manage cancer diseases. During anti-
inflammatory activities, nuclear factor-κB (NF-κB) expres-
sion regulated by zingerone and the activities of interleu-
kins are also reduced. Apoptosis also gets inhibited by use 
of this compound which regulates the caspases enzyme 
activities. It has also high antioxidant properties and in-
duce the activity of ROS scavenging enzymes to control 
ROS production during stress (21). It has been also report-
ed that zingerone treatment can reduce colon cancer and 
hepatocellular cancer and also effective against tumors by 
inhibiting cell cycle proteins (23-25). Several important 
pharmacological activities like anticancer, antitumor, anti-
oxidant, anti-inflammatory of zingerone are discussed in 
this review.  
Biological importance    
As zingerone is one the important compound of ginger, it 
retains various types of medicinal and pharmacological 
properties. Zingerone is also a nontoxic compound. It has 
no side effects and is obtained from natural sources. 
Anticancer and Antitumor activities  
Zingerone derived from ginger has anticancer properties 
against colon cancer, hepatocellular carcinoma and tumor 
Fig. 1. Chemical structure of zingerone  
Fig. 2. Conversion of gingerol to zingerone. 
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development (20, 23, 25). 2 mM of zingerone dissolved with 
dimethyl sulfoxide (DMSO) prevents the rapid divisions of 
cancer cells by inhibiting the expression of cyclin D1 (24). 
Cyclin D1 is a cell cycle check point protein, required at G1 
phase of cell cycle. The G1 phase components undergo S 
phase, G2 phase and M phase to complete a cell division 
(Fig. 4). Cyclin-dependent kinase (CDK) inhibitor p21 inhib-
its the cell cycle protein complexes like cyclin-cdk2, cdk1, 
cdk4/6 and stops cell cycle at S and G1 phase during Ultra-
violet B (UVB) induce cell damage. However, 40 mg/kg of 
this compound has the capacity to reduce the production 
of p21 and allow the cell to complete cell cycle during divi-
sion (25). The derivative of this compounds is found effec-
tive against hepatocellular carcinoma (HCC) and its metas-
tasis as well as found to act on TGF-β1, which regulates 
epithelial mesenchymal transition (EMT) for metastasis 
(Fig. 4) of HCC (18). Further, its nanoparticles (10 mg/kg) 
have efficiency to reduce cell proliferation in tumor cells 
and enhance the pharmacological properties of the com-
pound (26). In cancer cells, the zingerone nanoparticles 
increase DNA damage, which subsequently leads cancer 
cells to apoptosis. It acts over hepatocellular cancer cells 
and lead them to apoptosis by cascades of caspase signal-
ling pathways. Caspase 3 activity is induced by this com-
pound and it cleaves poly (ADP-ribose) polymerase (PARP) 
which is mainly responsible for death of cancer cells (24, 
26). The effect of zingerone (40 mg/kg) against chemical 
induced colon cancer is tested in rat model (25).  The colon 
cancer is reduced by inhibiting the formation of aberrant 
crypt foci (ACF) in colon tissue (25). ACF are abnormal tubu-
lar glands reside in the colon and rectum, which further 
leads to colon cancer (27). Tumor development is con-
trolled by angiogenesis and this compound is also found 
effective against tumor angiogenesis. Ma-
trix metalloproteinases (MMPs) are re-
quired for degradation of basement mem-
brane during angiogenesis. The tumor 
cells treated with zingerone further retire 
angiogenesis by decreasing the MMP-2 
and MMP-9 activities (20).  
Antioxidant activities   
Zingerone has an efficient role against 
reactive oxygen species (ROS), peroxides 
and free radicals. The antioxidant activi-
ties generally inhibit xanthine oxidase 
activity as xanthine oxidase is recruited 
ROS production (17). The ROS includes 
singlet oxygen (1O2), hydroxyl radical 
(•OH), superoxide anion (O2¯), hydroxyper-
oxyl (HO2•), peroxyl (ROO•), alkoxyl (RO•), 
ozone (O3), hypochlorous acid (HOCl), per-
oxynitrite (ONOO¯), hydrogen peroxide 
(H2O2) (28). It triggers the activity of ROS 
detoxifying enzymes like superoxide dis-
mutase (SOD), catalase (CAT), glutathione 
(GSH), glutathione reductase (GR) and 
glutathione peroxidase (GPx) (17-19). 
Structurally zingerone contains hydroxyl 
groups in the aromatic rings and double 
bonds between C3 and C4 carbon (29). This may support the 
antioxidant properties of zingerone. Alloxan is an organic 
compound induce diabetes by destroying insulin producing 
beta cells in pancreas and also produce ROS simultaneous-
ly. Zingerone is found effective to reduce the ROS level pro-
duced by alloxan by increasing the activities of SOD, CAT, 
GSH and GPx as compare to untreated diabetic rats (30). In 
exposure to radiations, various ROS products are also gen-
erated which can be controlled by zingerone (31). 
Zingerone is known to produce more numbers of scaveng-
ing enzymes when treated to radiation exposed cells. Apop-
tosis can be prevented by the application of zingerone. Two 
important proteins Bcl-2 and Bax crosstalk play important 
role in regulation of apoptosis. Bcl-2 is an anti apoptic pro-
tein and Bax is a pro apoptic protein. Bax protein gets acti-
vated in response to ROS production and leads to apopto-
sis. However, application of zingerone increases the effi-
ciency of Bcl-2 which subsequently acts over Bax (Fig. 4) 
and inhibit apoptosis (29). An elevated amount of ROS is 
produced during ischemia–reperfusion injury in neuron 
mitochondrial cells. This leads to apoptosis of neuron cells 
by involving intrinsic pathway of programmed cell death 
(iPCD) (29, 32). The application of zingerone (50 mg and 100 
mg/kg) also lower the expression of Apaf -1 and Bax pro-
teins in the neural cell during ischemia–reperfusion injury 
(32). Nitrite and peroxynitrite anions are nitrogen reactive 
compounds formed during oxidative stress. These are the 
product of reaction between nitric oxide (NO) and oxygen. 
By the use of zingerone (25 μg/ml) it competes with oxygen 
and is attached to NO to prevent the formation of nitrogen 
reactive compounds (29). Cisplatin is a compound used in 
chemotherapy, produces various types side effects. Cispla-
tin treated organisms mainly suffer from nephrotoxicity 
Fig. 3. Biological importance of zingerone  
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disease, which reduces the antioxidant enzymes and in-
creases malondialdehyde (MDA) production by lipid peroxi-
dation.  Zingerone in an amount of 50 mg/kg restores the 
activity of CAT and GPx. It also reduces MDA production 
(33). Zingerone (500 ug/ml) showed its protective effect 
against in vitro DNA damage induced by stannous chloride 
(34). Streptozotocin/high fat diet (STZ/HFD) causes type-2 
diabetes and increase ROS production in Wistar rat. ROS 
level decrease by zingerone as antioxidant enzymes in-
crease their own activities (35). Ethanol, the so-called alco-
hol can increase ROS production in living cells by reducing 
the scavenging enzyme activities (19).  
Anti-inflammatory activities  
Proinflammatory cytokines such as interleukins (IL1-b, IL-6, 
IL-2) and tumor necrosis factor alpha (TNF-α) are increased 
during chemical induced diabetes. IL1-b, IL-6, IL-2 and TNF-
α have an important role in malfunctioning the β cells of 
pancreas during diabetes (30). These inflammatory cyto-
kines are found to decrease in diabetes rats by the treat-
ment of zingerone. It is in amount of 50 mg/kg successfully 
reduced the cisplatin induced inflammation by limiting TNF
-α production (Fig. 4) in Wistar rats (33). UVB is very harmful 
radiation mainly responsible for epithelial cell damage and 
show inflammation by increasing the level of cytokines in 
keratinocyte stem cells (KSCs) (36). During UVB exposure, 
the elevated TNF-α employs inflammatory cells which se-
crete elastases and collagenases. They further lead to aging 
or skin damage (36-39). NF-κB pathway is one of the im-
portant signalling pathways to show inflammation by the 
cell under stress. Lipopolysaccharides produce proinflam-
matory cytokines in living organisms. Lipopolysaccharides 
induced acute systemic inflammation is controlled by 
zingerone. Zingerone reduce the production of p65 proteins 
in the cells which suffer from acute systemic inflammation 
(40). P65 protein is attached with p50 protein to form a pro-
tein dimer in NF-κB signalling pathway. This protein dimer 
is transferred to nucleus from cytosol after the proteosomal 
degradation of phosphorylated IκBα, which subsequently 
initiate transcription of proinflammatory cytokines to show 
inflammation (41). Inflammatory bowel disease (IBD) is one 
the important cause of colitis. NF-κB and IL- 1β are im-
portant proteins expressed during 2,4,6-trinitrobenzene 
sulphonic acid (TNBS) induced colitis. The microarray study 
for gene expression showed that ginger and zingerone (100 
mg/kg) application reduce the expression of NF-κB and IL- 
1β in TNBS induced colitis (42).  Ethanol consumption also 
shows inflammatory response in hepatic cells through NF-
κB and leads to hepatoxicity.  Zingerone (20 mg/kg) treat-
ment increase the number of anti-inflammatory Nrf-2 (basic 
leucine zipper (bZIP) protein) protein and decrease NF-κB 
expression which reflects reduction in hepatotoxicity by 
zingerone (19). The probable mechanism behind zingerone 
(100 mg/kg) mediated anti-inflammatory therapy is inhibi-
tion of inflammatory genes expression like toll like receptor 
4 (TLR4), RelA, NF-kB2, TNF-α, iNOS, COX-2 (43). Peroxi-
some proliferator-activated receptors (PPARs) is associated 
with various types of biological activities like increasing cell 
proliferation, glucose and lipid metabolism, insulin sensi-
tivity, tissue remodelling and inflammations. PPARs activi-
ties is increased by zingerone (8 mg/kg), which further su-
press NF-kB and prevent inflammation (44). 
Sl. 
No. Biological activities Sample/organism Effective amount of Zingerone References 
1. Anticancer, Antioxidant, Anti-hyperproliferative Rat (Colon) 100 mg/kg (23) 
2. Anticancer Human (Neuroblastoma cells) 2 mM (Dissolved with dimethyl sulfoxide) (24) 
3. Antitumor Mouse (Renca cells) 10 mg/kg (26) 
4. Antitumor Human (Hepatoma cells) 50 uM (nano sized (1.4 nm)) (Dissolved with ethanol) (26) 
5. Antitumor Mouse (Renca cells) 20 mg/kg (20) 
6. Anti-inflammation Rat 200 mg/kg (52) 
7. Anti-inflammation Rat (Liver) 100 mg/kg (53) 
8. Anti-inflammation, Anti-fibrotic Rat (Liver) 20 mg/kg (54) 
9. Anti-inflammation, Antioxidant, Anti-hyperlipidemic Rat (Hepatic cells) 20 mg/kg (19) 
10. Anti-inflammation Rat (kidneys) 8 mg/kg (44) 
11. Anti-inflammation Mouse (Liver) 100 mg/kg (43) 
12. Anti-inflammation Mouse 0.72 mg/kg (36) 
13. Anti-inflammation Mouse (Colon) 100 mg/kg (42) 
14. Anti-inflammation, Antioxidant, Antiapoptic Rat 25 mg/kg (55) 
15. Antioxidant, Antihyperlipidemic, Antithrombotic Rat (Heart) 6 mg/kg (48, 49) 
16. Antioxidant, Anticancer Rat (Colon) 40 mg/kg (25) 
17. Anti-Fxa and Anti platelet Human (Umbilical vein endothelial cells) 50 uM (Dissolved with dimethyl sulfoxide) (22) 
18. Antiapoptic Rat (Heart) 6 mg/kg (50) 
19. Antiangiogenic Mouse (Renca cells) 20 mg/kg (20) 
20 Antiapoptic Human (Lymphocytes) 10 ug/ml (31) 
21 Antioxidant Human (Lymphocytes) 10 ug/ml (treatment for more than 1hr) (31) 
Table 1. Biological activities of Zingerone  
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Antilipidemic activities  
Alcohol was also involved to increase lipids like cholesterol, 
triglycerides, free fatty acids, phospholipids and low-
density lipoproteins. Zingerone has an emerging role in 
antihyperlipidemic and antiapoptotic properties (45). The 
elevated expression of TNF-ɑ and IL-6 is reduced by 
zingerone. Triglyceride and cholesterol levels are de-
creased by zingerone. Nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase 4 (NOX 4) is upregulated by 
zingerone to prevent diabetic nephropathy (46).  
Other biological activities  
In a report of 2015, it was found that about 15.9 million of 
people suffers from myocardial infarction (47). The pre-
treated rats with zingerone showed prevention mechanism 
against isoproterenol induced myocardial infarction. This 
result concludes that zingerone is effective to protect heart 
from myocardial infarction disease (48, 49). The apoptosis 
responsive genes like Fas-receptor, caspase-8, caspase-9 
and caspase-3 are found down regulated due to zingerone 
in myocardial infarction. Bcl-2 and Bcl-xL are upregulated 
whereas Bax and Bad genes are down regulated in 
zingerone treated myocardial infarction tissue (induced by 
isoproterenol) (50). Zingerone also decreases biofilm for-
mation and subsequently enhances ciprofloxacin activity in 
Pseudomonas aeruginosa (43). 
 Osteoblast differentiation is the process leading to 
osteogenesis and boosted by zingerone in the mesenchy-
mal stem cells. mRNA Runx2, involved differentiation is 
enhanced by zingerone treatment. Zingerone may deposit 
calcium, which is responsible for osteogenesis (51). 
 Apart from this, zingerone has also the efficiency to 
act as antithrombosis agent. Thrombosis generally takes 
place by conversion of FX to FXa, which further converts 
prothrombin to thrombin and sequentially again converts 
fibrinogen to fibrin. In addition to fibrin deposition, Plate-
lets activated and aggregated to clot blood. But zingerone 
inhibits FXa formation and platelet aggregation (22). 
 
Conclusion 
Zingerone is used against diseases like myocardial infarc-
tion, hepatic cancer, colon cancer, neurological disorders 
and many other diseases. It has many important pharmaco-
logical activities like antioxidant, anticancer, antiinflamma-
tion, antithrombotic and various other activities. Zingerone 
is also found to regulate important genes like TGF-β, NF-κB, 
TNF-α and cytokines like interleukins in the signalling path-
way. But the actual mechanism involved is still unknown. 
Extensive studies are required to elucidate the exact mech-
anism of this compound in various disease responses. More 
studies can be also focused on the biological activities of 
zingerone after cooking in comparison to its crude form. 
This review will further help in potential drug discoveries 
Fig. 4. Zingerone is involved in signalling pathways against various diseases.  
Cancer metastasis is controlled by zingerone by inhibiting TGF-β1. EMT is controlled by TGF-β1 and is responsible for converting PEC to MMC, which further lead to 
cancer metastasis. Zingerone regulates NF-kB signalling in inflammation. Apoptosis and cancer are also regulated by zingerone. Zingerone induce Bcl 2 expression 
and supress Bax expression to inhibit cancer. Cell cycle check point protein complexes are inhibited by zingerone during cancer development. TGF-β1 (Transforming 
growth factor-beta 1), EMT (Epithelial mesenchymal transition), PEC (Polarized epithelial cells), MMC (Motile mesenchymal cells), NF-kB (Nuclear factor kappa beta), 
IL (Interleukin), TNF (Tumor necrosis factor). 
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from ginger plant using zingerone. However, the contribu-
tions of zingerone to the pharma as well as medicinal in-
dustries can be very high for multiple therapies. In addition, 
this compound in nanoform showed effective activities 
than its crude form. As so many studies on its dietary sup-
plements for various pharmacological activities have been 
reported, it can be adopted by pharma companies to devel-
op novel drug molecules. The multiple bioactivities of 
zingerone will also further definitely help scientific commu-
nities to get depth knowledge on it and its importance in 
various health sectors. 
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